AVMXY - Avita Medical Limited

Other OTC - Other OTC Delayed Price. Currency in USD

Avita Medical Limited

28159 Avenue Stanford
Suite 220
Valencia, CA 91355
United States

IndustryMedical Devices
Full Time Employees55

Key Executives

NameTitlePayExercisedYear Born
Dr. Michael S. PerryCEO & DirectorN/AN/A1959
Mr. Timothy RooneyChief Admin. Officer & Interim CFON/AN/AN/A
Mr. Andrew QuickChief Technology OfficerN/AN/AN/A
Ms. Erin LibertoChief Commercial OfficerN/AN/AN/A
Mr. Adam KelliherConsultantN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Avita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It offers regenerative products for the treatment of burns, chronic wounds, and aesthetics indications. The company's patented and proprietary collection and application technology provides treatment solutions derived from a patient's own skin. Its lead product, RECELL System, is used in the treatment of various skin defects, such as burns and plastic reconstructive procedures. The company also offers ReGenerCell for chronic wounds and ReNovaCell for the restoration of pigmentation. Avita Medical Limited is based in Valencia, California.

Corporate Governance

Avita Medical Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.